A prospective study of urinary oestrogen excretion and breast cancer risk
1996

Urinary Oestrogen Excretion and Breast Cancer Risk

Sample size: 1000 publication Evidence: moderate

Author Information

Author(s): TJA Key, DY Wang, JB Brown, C Hermon, DS Allen, JW Moore, RD Bulbrook, IS Fentiman, MC Pike

Primary Institution: Imperial Cancer Research Fund

Hypothesis

High levels of endogenous oestrogens increase the risk for developing breast cancer.

Conclusion

High levels of endogenous oestrogens in post-menopausal women are associated with increased breast cancer risk, while the relationship in premenopausal women is unclear.

Supporting Evidence

  • 69 subjects were diagnosed with breast cancer after urine collection.
  • Among premenopausal women, cases excreted less oestrogen than controls.
  • Among post-menopausal women, higher oestrogen excretion was associated with increased breast cancer risk.

Takeaway

This study looked at how much estrogen women excrete in their urine and found that post-menopausal women with higher estrogen levels are more likely to get breast cancer, but it's not clear for younger women.

Methodology

The study measured concentrations of oestrone, oestradiol, and oestriol in 24-hour urine samples from women and followed them for breast cancer diagnosis.

Potential Biases

There is some overrepresentation of cigarette smoking among the controls.

Limitations

The method of selecting the study group may have introduced some bias.

Participant Demographics

Women aged 34 years and above, both premenopausal and post-menopausal.

Statistical Information

P-Value

0.022 for oestradiol and 0.016 for total oestrogens.

Confidence Interval

95% CI for various odds ratios provided in the text.

Statistical Significance

p=0.022 for oestradiol and p=0.016 for total oestrogens.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication